SLEEP RESEARCH · DEEP DIVE
DSIP: What 50 Years of Delta Sleep-Inducing Peptide Research Found
In 1977 Swiss researchers isolated a nine-amino-acid peptide that deepened slow-wave sleep in rabbits. Half a century on, here is what the studies actually showed, and what they did not.
In 60 seconds
DSIP was found because it increased delta waves, the signature of deep sleep, when infused into rabbit brains. Human studies are small and mixed: one double-blind insomnia study found weak improvements. Its receptor is still unknown.
- DSIP was named for increasing delta waves in rabbit brains.
- One double-blind insomnia study found weak, partly uncertain effects.
- Its receptor is still unknown.
What it is
A nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) first isolated from rabbit blood during induced sleep.
What researchers looked at
Delta-wave EEG activity in animals, sleep efficiency and sleep latency in small human studies, and stress-hormone interactions.
What’s still unknown
Its receptor and exact mechanism, and whether effects are reliable in people.
The 1977 discovery
The original paper describes a peptide that, infused into the brain, increased slow-wave (delta) and spindle activity on the EEG. Its nine-amino-acid sequence was determined and synthetic versions were made — the starting point for decades of follow-up work.
What human studies found
A double-blind study gave DSIP or placebo to 16 people with chronic insomnia over three nights. Objective sleep efficiency was higher and sleep latency shorter with DSIP, but the authors judged the effects weak and possibly partly due to a change in the placebo group, and subjective sleep quality did not change.
Reviews from 1984 and 2001 describe DSIP as a peptide with many reported effects — sleep, stress hormones, pain modulation — but an unresolved mechanism. That honest uncertainty is the state of the field.
Why deep sleep matters to researchers
Deep (slow-wave) sleep is when the largest growth-hormone pulse of the day occurs and when memories are consolidated. In healthy men, deep sleep fell from about 19% of the night in early adulthood to about 3% by midlife. A compound that targets delta sleep is therefore an attractive research tool, which is why DSIP keeps attracting interest.
Related research compounds
Epitalon comes from pineal-gland research and is studied for melatonin rhythm and ageing markers. Selank is studied for anxiety and stress responses. Both have been studied separately from DSIP; no study has tested them together.
KEY TAKEAWAYS
- DSIP was named for increasing delta waves in rabbit brains.
- One double-blind insomnia study found weak, partly uncertain effects.
- Its receptor is still unknown.
- Deep sleep falls sharply from early adulthood to midlife.
Sources · PubMed
- Characterization of a delta-electroencephalogram (-sleep)-inducing peptide · Proc Natl Acad Sci U S A 1977 · PMID 265572
- Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study · Neuropsychobiology 1992 · PMID 1299794
- Delta-sleep-inducing peptide (DSIP): a review · Neurosci Biobehav Rev 1984 · PMID 6145137
- Delta sleep-inducing peptide · Eur J Anaesthesiol 2001 · PMID 11437870
- Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men · JAMA 2000 · PMID 10938176
- Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties · Int J Mol Sci 2025 · PMID 40141333
